Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $78.30B | $79.91B | $73.90B | $73.92B | $71.95B | $71.61B | $82.89B | $84.71B |
| Cost of revenue | $61.59B | $62.31B | $58.01B | $58.76B | $57.43B | $57.54B | $67.54B | $69.06B |
| Gross profit | $16.72B | $17.60B | $15.89B | $15.15B | $14.52B | $14.07B | $15.35B | $15.65B |
| Gross margin | 21.3% | 22.0% | 21.5% | 20.5% | 20.2% | 19.7% | 18.5% | 18.5% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $2.33B | $2.12B | $1.92B | $2.08B | $2.17B | $2.19B | $2.37B | $2.24B |
| EBITDA | $3.87B | $3.72B | $3.36B | $3.50B | $3.54B | $3.35B | $3.71B | $3.61B |
| Net income | $786.0M | −$254.0M | −$188.0M | $29.0M | $663.0M | $1.00B | $1.37B | $930.0M |
| Net margin | 1.0% | -0.3% | -0.3% | 0.0% | 0.9% | 1.4% | 1.7% | 1.1% |
| EPS (diluted) | 1.06 | -0.34 | -0.24 | 0.04 | 0.82 | 1.27 | 1.83 | 1.29 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds FNILX.
No tracked institution reports a position in FNILX as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-12 | $0.2470 | 2025-12-15 |
| 2024-12-13 | $0.2280 | 2024-12-16 |
| 2023-12-27 | $0.0040 | 2023-12-28 |
| 2023-12-15 | $0.2220 | 2023-12-18 |
No one on the platform has traded FNILX yet.
| +0.36% |
| $17.6B |
| — |
| SMGIXColumbia Contrarian Core Fund | $41.76 | +1.14% | $18.7B | — |
| TRMCXT. Rowe Price Mid-Cap Value Fund | $38.48 | +0.52% | $15.9B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.